Helena Ågerstam

Forskare, Biträdande
Fler filtreringsmöjligheter
  1. 2020
  2. 2019
  3. FLT3 N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis

    Axel Hyrenius-Wittsten, Mattias Pilheden, Antoni Falqués-Costa, Mia Eriksson, Helena Sturesson, Pauline Schneider, Priscilla Wander, Cristian Garcia-Ruiz, Jian Liu, Helena Ågerstam, Anne Hultquist, Henrik Lilljebjörn, Ronald W. Stam, Marcus Järås & Anna K. Hagström-Andersson, 2019, I: Leukemia. 33, 9, s. 2310-2314

    Forskningsoutput: TidskriftsbidragLetter

  4. 2018
  5. CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting

    Niklas Landberg, Sofia von Palffy, Maria Askmyr, Henrik Lilljebjörn, Carl Sandén, Marianne Rissler, Satu Mustjoki, Henrik Hjorth-Hansen, Johan Richter, Helena Ågerstam, Marcus Järås & Thoas Fioretos, 2018 feb 28, I: Haematologica. 103, 3, s. 447-455

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2017
  7. Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells

    Maria Askmyr, Sofia Von Palffy, Nils Hansen, Niklas Landberg, Carl Högberg, Marianne Rissler, Helena Ågerstam & Thoas Fioretos, 2017 okt 1, I: PLoS ONE. 12, 10, e0186035.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

    Niklas Landberg, Arta Dreimane, Marianne Rissler, Rolf Billström & Helena Ågerstam, 2017, I: European Journal of Haematology. 99, 5, s. 442-448 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2016
  10. IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models

    Helena Ågerstam, Nils Hansen, Sofia von Palffy, Carl Sandén, Kristian Reckzeh, Christine Karlsson, Henrik Lilljebjörn, Niklas Landberg, Maria Askmyr, Carl Högberg, Marianne Rissler, Kimmo Porkka, Hans Wadenvik, Satu Mustjoki, Johan Richter, Marcus Järås & Thoas Fioretos, 2016 dec 8, I: Blood. 128, 23, s. 2683-2693

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2015
  12. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.

    Helena Ågerstam, Christine Karlsson, Nils Hansen, Carl Sandén, Maria Askmyr, Sofia von Palffy, Carl Högberg, Marianne Rissler, Mark Wunderlich, Gunnar Juliusson, Johan Richter, Kjell Sjöström, Ravi Bhatia, James C Mulloy, Marcus Järås & Thoas Fioretos, 2015, I: Proceedings of the National Academy of Sciences. 112, 34, s. 10786-10791

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome.

    Niklas Landberg, Nils Hansen, Maria Askmyr, Helena Ågerstam, Carin Lassen, Marianne Rissler, H H Hansen, S Mustjoki, Marcus Järås, Johan Richter & Thoas Fioretos, 2015, I: Leukemia. 30, 1, s. 255-258

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2014
  15. 2013
  16. Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.

    Maria Askmyr, Helena Ågerstam, Nils Hansen, Sandra Gordon, Alexandros Arvanitakis, Marianne Rissler, Gunnar Juliusson, Johan Richter, Marcus Järås & Thoas Fioretos, 2013, I: Blood. 121, 18, s. 3709-3713

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.

    Nils Hansen, Helena Ågerstam, Martin Wahlestedt, Niklas Landberg, Maria Askmyr, Mats Ehinger, Marianne Rissler, Henrik Lilljebjörn, Petra Johnels, J Ishiko, J V Melo, Alexander Whalen, David Bryder, Marcus Järås & Thoas Fioretos, 2013, I: Leukemia. 27, s. 130-135 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2010
  19. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.

    Marcus Järås, Petra Johnels, Nils Hansen, Helena Ågerstam, Panagiotis Tsapogas, Marianne Rissler, Carin Lassen, Tor Olofsson, Ole Weis Bjerrum, Johan Richter & Thoas Fioretos, 2010, I: Proceedings of the National Academy of Sciences. 107, 37, s. 16280-16285

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice

    Helena Ågerstam, Marcus Järås, Anna Andersson, Petra Johnels, Nils Hansen, Carin Lassen, Marianne Rissler, David Gisselsson Nord, Tor Olofsson, Johan Richter, Xiaolong Fan, Mats Ehinger & Thoas Fioretos, 2010, I: Blood. 116, 12, s. 2103-2111

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Molecular and functional studies of ABL1 and FGFR1 fusion oncogenes in myeloproliferative neoplasms

    Helena Ågerstam, 2010, Section of clinical genetics. 64 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  22. 2009
  23. 2007
  24. 2003
  25. HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects.

    Catharina Svanborg, Helena Ågerstam, Annika Aronson, Rolf Bjerkvig, Caroline Düringer, Walter Fischer, Lotta Gustafsson, Oskar Hallgren, Irene Leijonhuvud, Sara Linse, Anki Mossberg, Hanna Nilsson, Jenny Pettersson & Malin Svensson, 2003, I: Advances in Cancer Research. 88, s. 1-29

    Forskningsoutput: TidskriftsbidragÖversiktsartikel